{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:37:33Z","timestamp":1762375053520},"reference-count":72,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.euroneuro.2006.01.001","type":"journal-article","created":{"date-parts":[[2006,2,25]],"date-time":"2006-02-25T12:16:16Z","timestamp":1140869776000},"page":"491-497","source":"Crossref","is-referenced-by-count":24,"title":["Role of nigral NF\u03baB p50 and p65 subunit expression in haloperidol-induced neurotoxicity and stereotyped behavior in rats"],"prefix":"10.1016","volume":"16","author":[{"given":"M.","family":"Salda\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bonastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2006.01.001_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jnen\/59.2.151","article-title":"STAT3 and NF\u03baB activation precedes glial activity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei","volume":"59","author":"Acarin","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02244092","article-title":"Unaltered [3-H]-GBR-12935 binding after chronic treatment with dopamine active drugs","volume":"102","author":"Allard","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rat. Implications for tardive dyskinesia?","volume":"61","author":"Andreassen","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1476-5381.1996.tb15736.x","article-title":"Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats","volume":"119","author":"Andreassen","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.neuroscience.2003.08.058","article-title":"Oral dyskinesias and histopathological alterations in substantia nigral after long-term haloperidol treatment of old rats","volume":"122","author":"Andreassen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s007020050142","article-title":"Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin 1 A receptors","volume":"106","author":"Ase","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0893-133X(00)00086-5","article-title":"Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antispychotic drugs","volume":"23","author":"Bauer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/376167a0","article-title":"Embryonic lethality and liver degeneration in mice lacking the Rel A component of NF-kappa B","volume":"376","author":"Beg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","article-title":"An essential role for NF\u03baB in preventing TNF-\u03b1 induced cell death","volume":"274","author":"Beg","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib10","first-page":"822","article-title":"1-methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies","volume":"270","author":"Bloomquist","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1460-9568.2002.01903.x","article-title":"Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum","volume":"15","author":"Bubser","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410330516","article-title":"Neuroleptic medications inhibit complex I of the electron transport chain","volume":"33","author":"Buckhardt","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","article-title":"Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain","volume":"196","author":"Burt","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0149-7634(94)90001-9","article-title":"Free radicals mechanisms in schizophrenia and tardive dyskinesia","volume":"18","author":"Cadet","year":"1994","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib15","series-title":"Psychopharmacology: The Fourth generation of Progress","first-page":"1497","article-title":"Tardive dyskinesia: pathophysiology","author":"Casey","year":"1995"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib16","first-page":"5","article-title":"Tardive dyskinesia: pathophysiology and animal models","volume":"61","author":"Casey","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00733634","article-title":"Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus coeruleus are unaffected by acute and chronic haloperidol administration","volume":"10","author":"Cottingham","year":"1990","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/BF00441962","article-title":"Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia","volume":"98","author":"Ellison","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00403900","article-title":"Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats","volume":"10","author":"Ernst","year":"1967","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib72","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000080151","article-title":"Dexamethasone downregulate chemokine receptor CXCR4 and exerts neuroprotection against hypoxia\/ischemia-induced brain injury in neonatal rats","volume":"11","author":"Felszeghy","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0166-2236(84)80254-4","article-title":"Neurobiological susbtrates of tardive dyskinesias: the GABA hypothesis","volume":"7","author":"Fibiger","year":"1984","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00433091","article-title":"An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine","volume":"69","author":"Fray","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-328X(98)00330-1","article-title":"Activation of nuclear factor \u03baB in the rat brain after transient focal ischemia","volume":"65","author":"Gabriel","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/283569a0","article-title":"Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in subtantia nigra","volume":"283","author":"Gale","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s007020070089","article-title":"Haloperidol-induced meurotoxicity\u2014possible implications for tardive dyskinesia","volume":"107","author":"Galili-Mosberg","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1471-4159.2000.0750101.x","article-title":"NF-\u03baB mediates the cell survival-promoting action of an activity-dependent neurotrophic factor peptide","volume":"75","author":"Glazer","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib27","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1046\/j.1460-9568.2003.02917.x","article-title":"Decreased iNOS synthesis mediates dexamethasone-induced protection of neurons from inflammatory injury in vitro","volume":"18","author":"Golde","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s007020050234","article-title":"Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia","volume":"106","author":"Ikeda","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib29","first-page":"1485","article-title":"Tardive dyskinesia: epidemiology and clinical presentation","volume":"vol. 39","author":"Kane","year":"1995"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/exnr.2002.7967","article-title":"Lack of NF-\u03baB exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning","volume":"176","author":"Kassed","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molbrainres.2004.07.021","article-title":"Nuclear factor-kappa B p65 in NMDA-induced retinal neurotoxicity","volume":"131","author":"Kitaoka","year":"2004","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01245320","article-title":"An experimental model of tardive dyskinesia","volume":"33","author":"Klawans","year":"1972","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/syn.890120103","article-title":"Dopamine supersensitivity and D-1\/D-2 synergism are unrelated to changes in striatal receptor density","volume":"12","author":"LaHoste","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib34","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1073\/pnas.90.16.7451","article-title":"Striatal fos expression is indicative of dopamine D-1\/D-2 synergism and receptor supersensitivity","volume":"90","author":"LaHoste","year":"1993","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.17917","article-title":"Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover","volume":"197","author":"Lerner","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0306-4522(97)00447-8","article-title":"Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in susbtantia nigra but not ventral tegmental area in the rat","volume":"84","author":"Levinson","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1460-9568.2002.01944.x","article-title":"Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigrostriatal dopaminergic neurons directly related to \u201cearly onset\u201d vacuous chewing","volume":"15","author":"Marchese","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2003.10.005","article-title":"Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol","volume":"483","author":"Marchese","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(93)90448-Q","article-title":"D-1 but not D-2 dopamine stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor upregulation","volume":"231","author":"Marin","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0091-3057(93)90104-2","article-title":"D-1 and D-2 dopamine receptor-mediated mechanisms and behavioral supersensitivity","volume":"45","author":"Marin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(96)00461-1","article-title":"Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behavior","volume":"731","author":"Marin","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1098-2396(199606)23:2<89::AID-SYN4>3.0.CO;2-C","article-title":"Striatal c-fos levels do not correlate with haloperidol-induced behavioral supersensitivity","volume":"23","author":"Marin","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.2000.740443.x","article-title":"Roles of nuclear factor \u03baB in neuronal survival and plasticity","volume":"74","author":"Mattson","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib45","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jnnp.64.6.799","article-title":"Persistent loss of tyrosine hydroxyalse immunoreactivity in the substantia nigra after neuroleptic withdrawal","volume":"64","author":"Mazurek","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02253587","article-title":"Effect of haloperidol and clozapine on the density of \u201cperforated\u201d synapses in caudate, nucleus accumbens and medial prefrontal cortex","volume":"106","author":"Meshul","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(94)91117-7","article-title":"Haloperidol-induced morphological changes in striatum are associated with glutamate synapses","volume":"648","author":"Meshul","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib48","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archpsyc.1993.01820210057007","article-title":"Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia study","volume":"50","author":"Morgenstern","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1471-4159.2000.740647.x","article-title":"Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-\u03baB activation","volume":"74","author":"Nakai","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib50","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1046\/j.1471-4159.1995.65052057.x","article-title":"Neuroleptics up-regulate adenosine A2A receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia","volume":"65","author":"Parsons","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib51","series-title":"Neuroleptic-Induced Movement Disorders","first-page":"141","article-title":"Reanalysis of the dopamine theory of tardive dyskinesia the hypothesis of dopamine D1\/D2 imbalance","author":"Peacock","year":"1997"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib52","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1098-1136(199604)16:4<306::AID-GLIA3>3.0.CO;2-Y","article-title":"Induction of NF-\u03baB-like transcription factors in brain areas susceptible to kainate toxicity","volume":"16","author":"Perez-Otano","year":"1996","journal-title":"Glia"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib53","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1523\/JNEUROSCI.18-20-08236.1998","article-title":"Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappa B and neuroprotection by antioxidants","volume":"18","author":"Post","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/mol.53.1.33","article-title":"Nuclear factor-\u03baB contributes to excitotoxin-induced apoptosis in rat striatum","volume":"53","author":"Qin","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(95)00611-S","article-title":"Brain dopamine transporter: gender differences and effect of chronic haloperidol","volume":"692","author":"Rivest","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib56","first-page":"380","article-title":"MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies","volume":"268","author":"Rollema","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib57","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0091-3057(94)90085-X","article-title":"Possible genetic factors underlying the pathophysiology of tardive dyskinesia","volume":"49","author":"Rosengarten","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib58","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/00001756-199509000-00021","article-title":"Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex","volume":"6","author":"See","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(95)01114-5","article-title":"Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats","volume":"704","author":"See","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib60","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0092-8674(86)90807-X","article-title":"Inductibility of k immunoglobulin enhancer-binding protein NF\u03baB by a posttranslational mechanism","volume":"47","author":"Sen","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1471-4159.1999.0730353.x","article-title":"Activation of nuclear factor-\u03baB by nitric oxide in rat striatal neurones: differential inhibition of the p50 and p65 subunits by dexamethasone","volume":"73","author":"Simpson","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mp.4000249","article-title":"Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients","volume":"2","author":"Steen","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib63","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0028-3908(74)90084-7","article-title":"Behavioral hypersensitivity to apomorphine following chronic treatment with drugs which interfere with synaptic function of catecholamines","volume":"13","author":"Tarsy","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.pharmtox.42.082701.160735","article-title":"Glutamatergic mechanisms in schizophrenia","volume":"42","author":"Tsai","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib65","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1300233","article-title":"Differential effects of within-day continuous vs transient dopamine D-2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats","volume":"28","author":"Turrone","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib67","series-title":"Neuroleptic-Induced Movements Disorders","first-page":"225","article-title":"Rodent and other animal models of tardive dyskinesia during long-term neuroleptic drug administration. Controversies and implications for the clinical syndrome","author":"Waddington","year":"1997"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib68","first-page":"162","article-title":"Familial occurrence of tardive dyskinesia","volume":"42","author":"Weinhold","year":"1981","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2006.01.001_bib69","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.expneurol.2004.12.023","article-title":"Dexamethasone enhances NT-3 expression in rat hippocampus after traumatic brain injury","volume":"192","author":"Yang","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib70","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0891-5849(97)00435-8","article-title":"In vivo analysis of hydrogen peroxide and lipid radicals in the striatum of rats under long-term administration of a neuroleptic","volume":"24","author":"Yokoyama","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.euroneuro.2006.01.001_bib71","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1523\/JNEUROSCI.19-20-08856.1999","article-title":"Lack of the p50 subunit of nuclear factor-\u03baB increases the vulnerability of hippocampal neurons to excitotoxic injury","volume":"19","author":"Yu","year":"1999","journal-title":"J. Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X06000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X06000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T09:01:28Z","timestamp":1627117288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X06000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0924977X06000198"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2006.01.001","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}